Tiziana Life Sciences Ltd (NASDAQ:TLSA) is set to present at the Biotech Showcase in San Francisco from January 8-10, 2024. The company's Chief Operating Officer and Chief Medical Officer, Dr. Matthew Davis, will lead the presentation titled "Intranasal Anti-CD3 mAb Therapy to Enable Breakthroughs in Neuroinflammatory and Neurodegenerative Diseases" on Monday, January 8th, at 9:30 am PST in Room Yosemite-C.
The Markets by Proactive
Go to Proactive Australia
Proactive’s Australian coverage continues on .com